Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

AMTRA welcomes VMD prescribing and supply changes
AMTRA has welcomed changes to the way certain animal medicines can be prescribed.

New approach will maintain essential distribution channel for animal medicines)

The Animal Medicines Training Regulatory Authority (AMTRA) has welcomed changes made by the Veterinary Medicines Directorate (VMD) to the way certain animal medicines can be prescribed and supplied during the COVID-19 coronavirus crisis.

Announced this week, the policy allows registered animal medicine advisors (RAMAs) – otherwise known as SQPs - to prescribe and authorise the supply of animal medicines remotely, providing strict procedures are observed. This includes wormers, flukicides, flea treatments and vaccinations.

Under the new approach, the RAMA/SQP is still responsible for the prescription and supply and therefore must:

  • be the person that has the conversation/consultation with the animal owner
  • be the person that makes the prescribing decision
  • be satisfied that the person handing over or dispatching the prescribed product is competent to do so.

“In the current circumstances, if the only available RAMA/SQP at a registered premises is self-isolating, those requirements would prevent in-person supervision,” Stephen Dawson, AMTRA secretary general, explains.

”Enforcing those rules would also limit the possibility for the RAMA to be working from home in an effort to limit the number of people on the business premises.

He added: “AMTRA welcomes this new approach during the new unique challenges caused by the COVID-19 pandemic. This will maintain the essential distribution channel for animal medicines while safeguarding the health and safety of staff and customers.”

The approach has been adopted across the companion animal, farm, and equine sectors and will remain in place until at least 30 April 2020.

 

Become a member or log in to add this story to your CPD history

RCVS Knowledge appoints Veterinary Evidence editor-in-chief

News Story 1
 RCVS Knowledge has welcomed Professor Peter Cockcroft as editor-in-chief for Veterinary Evidence.

A world-renowned expert in evidence-based veterinary medicine, Prof Cockcroft will lead the strategic development and editorial quality of the open-access journal. He was previously in the role from 2017-2020.

Katie Mantell, CEO of RCVS Knowledge, said: "We are excited about the extensive knowledge of evidence-based veterinary medicine and clinical veterinary research that Peter brings, and we look forward to working with him over this next phase of the journal's development." 

Click here for more...
News Shorts
CVS Group hit by cyber attack

CVS Group, which owns more than 450 veterinary practices in the UK, has been hit by a cyber attack.

In a statement, the group said the incident involved unauthorised external access to a limited number of its IT systems. As soon as the attack was discovered, the group took its IT systems temporarily offline, causing 'considerable operational disruption'.

It has warned that the security steps taken and ongoing plans to move its operational systems and IT infrastructure to the Cloud are likely to have an ongoing impact over a number of weeks.

Due to the risk that personal information was accessed, CVS has informed the Information Commissioner's Office. The company is working with third party consultants to investigate the incident.